Navigation Links
Directed in Medical Technology

ASGE Urges Patients to Seek a Qualified Endoscopist Before Undergoing a Colonoscopy for Colorectal Cancer

... a thorough colonoscopy and that patients must take the bowel prep as directed by their physician allowing for a clear view of the colon to detect ... than ever in encouraging their patients to take their bowel prep as directed before the colonoscopy. A proper bowel prep allows the physician to ...

Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration

... and worldwide commercialization of certain other product candidates directed to a small number of targets other than CD20 that have been established ... develop and commercialize, on its own or with others, product candidates directed to all targets not included within the agreement, including CD37. About ...

Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations

... conditions and life-threatening diseases. Principal programs are directed toward gastroenterology, virology -- including human immunodeficiency ... treatment of prostate cancer -- a selectively targeted cytotoxic antibody directed against prostate-specific membrane antigen (PSMA). PSMA is a protein found ...

Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials

... conditions and life-threatening diseases. Principal programs are directed toward gastroenterology as well as the treatment of HIV infection and ... antibody drug conjugate -- a selectively targeted cytotoxic antibody directed against prostate-specific membrane antigen (PSMA), a protein found on the ...

Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors

... currently administering HDR primarily on breast and gynecologic cancers. The HDR brachytherapy program at Cancer Centers of North Carolina is directed by its board-certified radiation oncologists, Dr. John Reilly and Dr. Kolby Sidhu. "HDR brachytherapy is a very effective addition to our fight ...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

... pressure. Patients with a change in vision or a history of eye problems should be monitored by their health care provider. Use ASMANEX as directed by your health care provider, since its ability to work in your lungs depends on regular use. Maximum benefit may take 1 to 2 weeks or longer. If ...

BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza

... in-house in late-stage clinical trials for influenza and lymphoma. In addition, the Company has a pre-clinical portfolio of novel compounds, directed against infectious, cardiovascular and autoimmune disease targets, to create long-term sustainable value. The Company's strategic alliances with the ...

Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing

... be the reason why bleeding rates are lower with once-daily dosing." "This Phase II study was a decisive study for Daiichi Sankyo in that it directed us to the optimal dosing regimen to study in our Phase III clinical trial ENGAGE AF-TIMI 48 - the more convenient 60 and 30 mg once-daily doses," ...

ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients

... pressure. Patients with a change in vision or a history of eye problems should be monitored by their health care provider. Use ASMANEX as directed by your health care provider, since its ability to work in your lungs depends on regular use. Maximum benefit may take 1 to 2 weeks or longer. If ...

ADHD Genes Found; Known to Play Roles in Neurodevelopment

... 2,000 unrelated healthy children. The team used highly automated gene-analyzing technology at the Center for Applied Genomics at Children's Hospital, directed by Hakon Hakonarson, M.D., Ph.D., a co-leader of this study. The study team found a similar quantity of CNVs in both groups. However, distinct ...

Gene Findings Unlocking Reasons for Neuroblastoma Risk

... issue of Nature . The researchers made use of highly automated gene-analyzing technology at the Center for Applied Genomics at Children's Hospital, directed by Hakon Hakonarson, M.D., Ph.D., a co-author of both studies. They used specimens collected from around the world through the Children's Oncology ...

Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs

... families and patients: -Families of SMA has funded 5 multi-center clinical trials for existing drugs that have potential for SMA. -FSMA has directed and funded the leading new drug development program for a therapy specially designed to treat SMA. -Families of SMA is building a pipeline of drug ...

FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight

... treatment of type 2 diabetes mellitus. All inquiries regarding the Phase 2 data presented at ADA, or about the development of Syncria, should be directed to the contacts provided by GSK. To view the GSK press release, please click here . For more information about HGS, please direct inquiries ...

Back to Normal: Surgery Improves Outcomes for Spine Patients

... of $10,000 or a commitment or agreement to provide such benefits from a commercial entity (Medtronic). Also, a commercial entity (Medtronic) paid or directed in any one year, or agreed to pay or direct, benefits in excess of $10,000 to a research fund, foundation, division, center, clinical practice, or ...

Kinex Pharmaceuticals To Present at ASCO 2009 Annual Meeting

... Investigator from RPCI will deliver the presentation entitled "Results of a phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket directed SRC inhibitor, in patients with advanced malignancies." The presentation will provide data from this multi-center Phase 1 trial that utilized ...

New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns

... to lift restrictions on federal funding of human embryonic stem cell research. As part of the order, the National Institutes of Health (NIH) were directed to develop regulations "to help ensure that NIH-funded research in this area is ethically responsible, scientifically worthy, and conducted in ...

BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results

... in-house in late-stage clinical trials for influenza and lymphoma. In addition, the Company has a pre-clinical portfolio of novel compounds, directed against infectious, cardiovascular and autoimmune disease targets, to create long-term sustainable value. The Company's strategic alliances with the ...

BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009

... in-house in late-stage clinical trials for influenza and lymphoma. In addition, the Company has a pre-clinical portfolio of novel compounds, directed against infectious, cardiovascular, and autoimmune disease targets, to create long-term sustainable value. The Company's strategic alliances with ...

Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin

... trial of Sanaria's candidate malaria vaccine is a watershed event. It is the culmination of a remarkable translational research effort by Sanaria directed at realizing the dream of a practical malaria vaccine preparation based upon whole parasites," states Michael Good, Director of the Queensland ...

Avon Protection Systems Issues Correction/Clarification on ST53 SCBA System

... Avon Protection Systems regrets any misunderstanding caused by the March 10 news release. Questions regarding the ST53 SCBA system should be directed to Mark Williamson, Marketing Manager for Avon-ISI, at 678-495-3725 or via e-mail at mark.williamson@avon-rubber.com " target="_new"> ...

Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion

... says. "Primary healthcare services and governments have failed to respond to families' complex needs for long-term support. Attention needs to be directed towards the development of age-appropriate healthcare, a long-term care policy, and mechanisms for ensuring, as a right, the social protection of ...

AndroScience Corporation Announces Phase 2a Study Results on ASC-J9(TM) for the Treatment of Acne

... clinical development and commercialization. Through enhancing androgen receptor protein degradation, ASC-J9(TM) represents the first topical agent directed at modulating the effect of androgens (male hormones), through the androgen receptor, a key causative factor in the pathogenesis of acne. ...

For Iraq Veterans, Headaches Continue After Traumatic Brain Injury

... among soldiers." The study was supported by the Uniformed Services University of the Health Sciences through a grant from the Congressionally directed Medical Research Program. The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is ...

BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine

... response and one partial response were observed. These results confirm the positive interim data reported in 2008 and show that MVA-BN(R)-based, HER2 directed vaccination is a biologically active treatment for patients with HER2 positive breast cancer; however the overall immune response was moderate. ...

Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections

... in-house in late-stage clinical trials for influenza and lymphoma. In addition, the Company has a pre-clinical portfolio of novel compounds, directed against infectious, cardiovascular, and autoimmune disease targets, to create long-term sustainable value. The Company's strategic alliances with ...

Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference

... inhibition (HAI) responses, which have been shown to be important for protection against influenza disease. Novavax's VLP candidate is directed against the H5N1 A/Indonesia/05/2005 avian influenza strain. This strain of avian influenza emerged in humans in Indonesia in 2005 and has caused 135 ...

Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis

... the treatment and study of PF including The University of Chicago , University of Michigan , and the David Geffen School of Medicine at UCLA and directed more than $400,000 in combined research funding since 2006 through its partnership with the American Thoracic Society (ATS). Complete details on CPF ...

Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program

... include, Inosine for the treatment of spinal cord injury and stroke, Oncomodulin for the treatment of ocular injury and disease and research programs directed at a number of regenerative therapies including bone repair. The Company has a robust molecular imaging development program targeting diagnosis of ...

ESBATech's Antibody Fragment Enters Phase Ib/IIa in Ophthalmology

... in patients, as well as assess the preventive activity on ocular inflammation resulting from the surgery. ESBA105 is a single-chain antibody fragment directed against TNF-alpha, a major mediator of inflammation. The study contains a randomized, double-blind, placebo controlled part and is being conducted as ...

Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk

... guidelines and, for the safety of customers, has withdrawn other products from sale that contain peanut ingredients implicated in this outbreak, as directed by the FDA and suppliers involved. Salmonella is an organism that can cause serious and sometimes fatal infections, particularly in young ...

Gene Abnormality Found to Predict Childhood Leukemia Relapse

... treatments, particularly for those in the high-risk group. "In the long term, our goal is to develop effective therapeutic interventions, directed toward vulnerabilities that leukemia cells acquire as a result of the genomic abnormalities identified through the TARGET initiative," said Malcolm ...

Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals

... is characterized by inadequate response to insulin or inadequate secretion of insulin as blood glucose levels rise. Therapies for type 2 diabetes are directed toward correcting the body's inadequate response with oral or injectable medications, or directly modifying insulin levels by injection of insulin or ...

Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target

... Roche has dosed the first patient in a Phase 1 pharmacokinetic clinical trial with a subcutaneous formulation using Enhanze Technology of a biologic directed to a Roche exclusive target. This has triggered a milestone payment under the agreement. Roche has also selected an additional exclusive ...

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

... clots from forming, medications that dissolve blood clots, catheter-directed thrombolysis (a surgical procedure where clot-dissolving medication is directed toward the blood clot), and thrombectomy, the surgical removal of a blood clot. Recognizing the deadly impact blood-clotting disorders have on ...

German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008

... their project should be chosen. Further information are available online at http://www.partec.com/worldaidsday . Applications should be directed by e-mail to worldaidsday@partec.com " target="_new"> worldaidsday@partec.com oder by telefax to +49-3581-874670. Technologically, the ...

Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows

... the cardiovascular risk of healthy patients with elevated CRP, should not prompt universal statin use in older adults, according to a national poll directed at health professionals. Some 1,212 participants took part in the online poll conducted by medical news site MedPage Today LLC ( www.MedPageToday.com ...

Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C

... Safety Information Relapse of drug addiction/overdose has occurred in patients on PEGINTRON therapy. Aggressive behavior sometimes directed towards others has occurred in patients with and without a previous psychiatric disorder during PEGINTRON and/or INTRON A treatment and follow-up. ...

Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer

... 30% of breast tumors. HER2 is considered today as a predictive marker for clinical benefit from trastuzumab, or Herceptin(R), a monoclonal antibody directed against the HER2 protein, in both primary and metastatic tumors. However current testing methods are inaccurate for as much as 20% of cases and this ...

Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds

... its research data. Kaiser Permanente's research program is funded in part by Kaiser Permanente's Community Benefit division, which in 2007 directed an estimated $1 billion in health services, technology, and funding toward total community health. About Kaiser Permanente Kaiser Permanente is ...

Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients

... Additional Safety Information Relapse of drug addiction/overdose has occurred in patients on PEGINTRON therapy. Aggressive behavior sometimes directed towards others has occurred in patients with and without a previous psychiatric disorder during PEGINTRON and/or INTRON A treatment and follow-up. If ...
Other Contents
(Date:8/18/2015)... , Aug. 17, 2015 Research ... addition of the "Global Biometric Authentication & ... - Estimation & Forecast, 2015-2020" report to ... authentication and identification systems market is expected to ... 2015 to 2020 and generate over $25 billion ...
(Date:8/12/2015)...  New research unveiled at Black Hat 2015 ... steal users, fingerprints. Information released today by HYPR ... on mobile devices, making the security of this ... mobile devices, HYPR Corp. recently released a biometric ... with strong cryptographic security. More information on this ...
(Date:8/10/2015)... , August 10, 2015 The ... offers comprehensive analysis of the global border security ... generate revenues of $16.4bn in 2015. Now: Border ... is an example of the business critical issue you need ... read visiongain ,s objective analysis of how this will ...
Breaking Biology News(10 mins):Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 4Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 5Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 7Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 8Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 9
(Date:8/29/2015)... , ... August 29, 2015 , ... ... company to freely market and sell Arterosil and Arterosil HP, and that all ... LLC (DHS) sued Vascular Health Sciences, LLC (VHS) in the United States District ...
(Date:8/28/2015)... ... August 28, 2015 , ... An online provider of CPAP ... the purchase of CPAP equipment more affordable by offering shipping at no cost to ... CPAP products and orders of any size. My Cpap Store is located in Las ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... An ... that local pizza maker Paul LaRocco has gone through to open a pizzeria in ... and permitting process tends to take several months, but the current process, having already ...
(Date:8/28/2015)... VA (PRWEB) , ... August ... ... Risk Management for Medical Devices:, Understanding the FDA’s Position and Best Practices ... MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally renowned expert ...
(Date:8/28/2015)... ... 28, 2015 , ... On May 30th, 2015, Best Drug Rehabilitation, a results-based ... With A Mission” benefit concert in Mendon, IL. Held in the Show Barn at ... support music education programs in the underfunded local school districts of Mendon at neighboring ...
Breaking Medicine News(10 mins):Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2
Other TagsOther Tags